Wisconsin VC News Roundup

Sift Healthcare raises $2.8 million

Sift Healthcare, which provides advanced decision support solutions for managing the increasingly complex healthcare revenue cycle, closed a $2.8 million round this summer. Rock River Capital Partners and Winnebago Seed Fund participated.

Read more: https://www.bizjournals.com/milwaukee/news/2020/08/07/milwaukee-sift-healthcare-raises-2-8-m-to-expand.html

SHINE Medical Technologies closes $80 million Series C

SHINE Medical Technologies closed an $80-million Series C financing round that included participation from Fidelity Management and Research Company LLC, new investors and the company’s current investors. The funds will be used to commercialize vital diagnostic and therapeutic isotopes.

Read more: https://shinemed.com/shine-closes-80-million/

American Family Ventures launches AFV Fund III

American Family Ventures’ AFV Fund III is a $213 million venture capital fund supported by multiple limited partners. It will focus on early-stage startups in the insurance industry as well as adjacent industries such as artificial intelligence, mobility and enterprise software.

Read more: https://medium.com/@amfamventures/american-family-ventures-launches-insurance-industry-backed-fund-a1bcb8d838c3

LÜM secures $3 million in funding round

The Wisconsin Alumni Research Foundation, Wisconsin Investment Partners and Bascom Investors participated in LUM’s recent $3 million seed round. The music streaming service also announced a partnership with Grammy-winning R&B and hip-hop artist Ne-Yo as its global ambassador.

Read more: https://www.wisbusiness.com/2020/lum-announces-partnership-with-grammy-winning-artist-ne-yo-after-securing-3m-in-a-second-seed-funding-round/

EnsoData nets $9 million Series A

Healthcare data company EnsoData announced a $9 million Series A financing round to be used toward launching new AI products in sleep and neurology. Venture Investors and Zetta Venture Partners led the round.

Read more: https://www.madisonstartups.com/ensodata-closes-9m-series-a/  

FluGen to develop coronavirus vaccine CoroFlu

FluGen, working alongside Bharat Biotech, has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu. It will build on FluGen’s flu vaccine candidate known as M2SR.

Read more: http://flugen.com/uw-madison-flugen-bharat-biotech-to-develop-coroflu-a-coronavirus-vaccine/